Dr. Hayato Urabe is Director of Investment Strategy and Management at the Global Health Innovative Technology (GHIT) Fund. As the Senior Director of Investment Strategy and Management, Dr. Urabe is responsible for driving the development of GHIT’s $300M+ investment strategy for product development (drugs, vaccines, and diagnostics) for malaria, tuberculosis, and Neglected Tropical Diseases.
He directs investment strategy of GHIT’s investments with 70+ global health R&D partnerships around the world, and oversees GHIT’s Innovation Exploration Strategy and Access Strategy. Prior to joining the GHIT Fund, Dr. Urabe held several positions across the energy, life sciences, and high-tech sectors focusing on strategy planning, global market analysis, business expansion and growth strategy development in the Silicon Valley.
Dr. Urabe completed his Doctor of Philosophy in Biomedical engineering from Brown University and received Master of Pacific International Affairs from the School of Global Policy & Strategy at University of California, San Diego.